Outsourced Pharma Capacity 2024 – Curia Biologics
webinar
internal
Watch as our Vice President of Biologics, Steve Lavezoli, explain how we’ve been a critical partner for biotech businesses of all sizes—small, midsize, and even large—supporting their needs from IND-enabling studies through late-stage commercial programs.